NCT04528680

Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2020-10-29Est. Completion: 2027-12-31

Enrollment target: 57 participants

Locations

Newly Diagnosed GlioblastomaMGMT-Unmethylated Glioblastoma

The Primary Objective of this study is to evaluate the efficacy and safety of teniposide in combination with temozolomid…

Multiple LocationsEst. completion Mar 2030

Glioblastoma, IDH-Wildtype

This phase II trial compares the effect of adding WSD0922-FU to temozolomide versus temozolomide alone in slowing diseas…

Scottsdale, United StatesEst. completion Aug 31, 2036

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.